Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-032537
Filing Date
2024-08-15
Accepted
2024-08-15 11:17:05
Documents
1
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2167
  Complete submission text file 0001493152-24-032537.txt   3607
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address
Aminov Erez (Reporting) CIK: 0001986112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41952 | Film No.: 241211103